Efficacy and security of traditional Chinese medicine in the treatment of perimenopausal insomnia in the Chinese population: a systematic review and meta-analysis of randomized controlled trials.

Researchers analyzed 48 studies involving over 5,000 women to examine whether Traditional Chinese Medicine (TCM) effectively treats insomnia during perimenopause—the transitional years before menopause when hormonal changes often disrupt sleep. The review compared TCM approaches (including herbal formulas, acupuncture, and other traditional treatments) against standard Western medications.

The results showed TCM interventions were 20% more effective than Western medicine at improving overall sleep outcomes. Women receiving TCM treatment experienced significantly better sleep quality, measured by the Pittsburgh Sleep Quality Index, which improved by an average of 2.57 points. Additionally, TCM treatments helped balance hormones by reducing elevated luteinizing hormone and follicle-stimulating hormone levels while increasing estradiol, which naturally declines during perimenopause.

Beyond sleep improvements, TCM also reduced perimenopausal symptoms overall, including hot flashes and night sweats. Mental health benefits were notable, with decreased anxiety scores (by 4.77 points) and depression scores. Perhaps most importantly, women using TCM experienced significantly fewer side effects—70% fewer adverse reactions compared to those taking Western medications.

For women struggling with perimenopausal insomnia, these findings suggest TCM offers a safer, potentially more effective alternative to conventional sleep medications. The hormonal balancing effects may address root causes rather than just symptoms. However, researchers noted that study quality varied, and more rigorous research is needed to confirm these benefits. If you're considering TCM for perimenopausal insomnia, seek treatment from a licensed acupuncturist or qualified Traditional Chinese Medicine practitioner.

This systematic review and meta-analysis examined 48 RCTs (n=5,037) comparing TCM interventions versus Western medicine for perimenopausal insomnia (PMI). TCM demonstrated superior overall efficacy (RR=1.20, 95% CI [1.17, 1.23]) with significantly fewer adverse events (RR=0.30, 95% CI [0.24, 0.38]). Sleep quality improvements were substantial, with PSQI scores decreasing by 2.57 points (MD=-2.57, 95% CI [-3.01, -2.14]). Hormonal parameters showed clinically meaningful changes: LH reduced by 4.51 mIU/mL, FSH by 8.67 mIU/mL, and E2 increased by 9.64 pg/mL. Additional benefits included reduced KMI scores (MD=-6.01), TCMS scores (SMD=-2.27), and improvements in SAS (MD=-4.77) and SDS (MD=-2.96) scores. While methodological heterogeneity limits certainty, TCM appears to offer multi-dimensional therapeutic benefits for PMI through sleep regulation, hormonal modulation, and psycho-emotional stabilization, with a favorable safety profile warranting clinical consideration.